Sudeep Pharma chairman and AGM

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

• To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended 31st March, 2026 together with the Reports of the Board of Directors and Auditors thereonMoreLess

  13 for0 against
• Re appointment of Mr Ajay Shrirang Kandelkar (DIN: 10773491) as a director, who retires by rotation and being eligible, offers himself for re appointment.

  13 for0 against
• To declare dividend on equity shares for the financial year ended 31st March 2026

  13 for0 against
• To Appoint Mr. Hemang Mehta, a proprietor of H. M. Mehta and Associates, Peer reviewed Practicing Company Secretary, as Secretarial Auditor of the Company for a term of 5 (Five) consecutive years and fix their remuneration.MoreLess

  13 for0 against
• Appointment of Mr. Milin Mehta as a Director (Non Executive and Non Independent).

  13 for0 against
• To ratify Sudeep Pharma Employee Stock Option Scheme 2025

  ›Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual Fund, quant Mutual Fund

  • Angel One Mutual FundGovernance and Transparency Concern: The Scheme provides discretion to the Committee to alter / vary Exercise Period at the employee level; the Scheme provides a broad range of Vesting period, which may lead to exercise of excessive discretion by the Board or the Compensation Committee and does not enable shareholders to take an informed decision; further, the Scheme provides discretion to the Nomination & Remuneration Committee to alter the vesting period at its discretion and hence indirectly granting them discretion to accelerate vesting.
  • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Exercise Price not disclosed as required under law. Governance and Transparency Concern: The Scheme provides discretion to the Committee to alter / vary Exercise Period at the employee level; the Scheme provides a broad range of Vesting period, which may lead to exercise of excessive discretion by the Board or the Compensation Committee and does not enable shareholders to take an informed decision; further, the Scheme provides discretion to the NRC to alter the vesting period at its discretion and hence indirectly granting them discretion to accelerate vesting.
  • HDFC Mutual FundESOPs are being granted at a deep discount to market price. We do not support the resolution.
  • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
  • quant Mutual FundRelated to the company's 2025 ESOP. Non-Compliant with SEBI (SBEB & SE) Regulations 2021: Exercise Price not disclosed as required under law. Governance and transparency concerns: Lack of clarity on vesting period, NRC discretion and extension to associate companies without provision for cost reimbursement.

  0 for9 against
• To approve the grant of employee stock options to the eligible employees of the subsidiary company(ies) of the Company under Sudeep Pharma Employee Stock Option Scheme 2025

  ›Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual Fund, quant Mutual Fund

  • Angel One Mutual FundGovernance and Transparency Concern: The Scheme provides discretion to the Committee to alter / vary Exercise Period at the employee level; the Scheme provides a broad range of Vesting period, which may lead to exercise of excessive discretion by the Board or the Compensation Committee and does not enable shareholders to take an informed decision; further, the Scheme provides discretion to the Nomination & Remuneration Committee to alter the vesting period at its discretion and hence indirectly granting them discretion to accelerate vesting.
  • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Interlinked with resolution #7.
  • HDFC Mutual FundThe company proposes to extend ESOP 2025 to eligible employees of its subsidiaries. While we support the extension of ESOP schemes to unlisted subsidiaries, we do not support the contours of the Scheme itself. Our view is linked to resolution #7. Hence, we do not support the resolution.
  • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
  • quant Mutual FundRelated to the company's 2025 ESOP. Non-Compliant with SEBI (SBEB & SE) Regulations 2021: Exercise Price not disclosed as required under law. Governance and transparency concerns: Lack of clarity on vesting period, NRC discretion and extension to associate companies without provision for cost reimbursement.

  0 for9 against
• To approve the grant of employee stock options to the eligible employees of the group company including associate company(ies) of the Company under Sudeep Pharma Employee Stock Option Scheme 2025

  ›Against Aditya Birla Sun Life Mutual Fund, Angel One Mutual Fund, Axis Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual Fund, quant Mutual Fund, UTI Mutual Fund

  • Aditya Birla Sun Life Mutual Fund, Axis Mutual FundThe company proposes to extend ESOP 2025 to eligible employees of group companies including associate companies, working in India or outside India. We do not support extension of ESOP schemes to group companies including associate companies, as they may have their own ESOP Schemes currently or in the future. Further, our view on this resolution is linked to resolution #7. Hence, we do not support the resolution.
  • Angel One Mutual FundGovernance and Transparency Concern: The Scheme provides discretion to the Committee to alter / vary Exercise Period at the employee level; the Scheme provides a broad range of Vesting period, which may lead to exercise of excessive discretion by the Board or the Compensation Committee and does not enable shareholders to take an informed decision; further, the Scheme provides discretion to the Nomination & Remuneration Committee to alter the vesting period at its discretion and hence indirectly granting them discretion to accelerate vesting. and Scheme proposed to be extended to Associate Companies without any affirmation on cost reimbursement.
  • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Interlinked with resolution #7. Governance Concern: Scheme proposed to be extended to Associate Companies without any affirmation on cost reimbursement.
  • HDFC Mutual FundThe company proposes to extend ESOP 2025 to eligible employees of group companies including associate companies, working in India or outside India. We do not support extension of ESOP schemes to group companies including associate companies. Further, our view on this resolution is linked to resolution #7. Hence, we do not support the resolution.
  • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
  • quant Mutual FundRelated to the company's 2025 ESOP. Non-Compliant with SEBI (SBEB & SE) Regulations 2021: Exercise Price not disclosed as required under law. Governance and transparency concerns: Lack of clarity on vesting period, NRC discretion and extension to associate companies without provision for cost reimbursement.
  • UTI Mutual FundOur view on this resolution is linked to resolution #7. Hence, we do not support the resolution.

  1 for12 against
• To Change the Remuneration of Mr. Ajay Shrirang Kandelkar (DIN: 10773491) as Whole Time Director w.e.f. 1st April 2026

  ›Against Mirae Asset Mutual Fund

  • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)

  12 for1 against
• To adopt new set of Articles of Association (AOA)

  ›Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual Fund, quant Mutual Fund

  • Angel One Mutual FundGovernance & Transparency Concern: Proposed AoA not disclosed / cannot be located.
  • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual FundCompliant with law. Governance & Transparency Concern: Proposed AoA not disclosed / cannot be located.
  • quant Mutual FundProvision for alternate director in AoA.

  6 for7 against